Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$11,370
-$1,173 QoQ
Shares Held
90
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,181
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DELTA ASSET MANAGEMENT LLC/TN holds $27,667,664 across 14 Drug Manufacturers - General names. GILD ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,142 | $10,194,863 | |
| 2 | ABBV |
AbbVie Inc.
|
30,429 | $7,657,153 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
75,264 | $4,336,711 | |
| 4 | PFE |
Pfizer Inc
|
105,462 | $2,539,524 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,334 | $1,584,919 | |
| 6 | LLY |
ELI LILLY & Co
|
671 | $804,817 | |
| 7 | AMGN |
Amgen Inc
|
999 | $361,757 | |
| 8 | GSK |
GSK plc
|
2,138 | $112,073 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,370 | 90 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $12,543 | 90 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $11,046 | 90 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $9,990 | 90 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $10,532 | 95 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $10,644 | 95 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||